View Post

Protein-based COVID-19 Vaccine Over 79% Effective

In COVID-19, Latest News by Precision Vaccinations

The JAMA Network today published the results from an Original Investigation on the Novavax COVID-19 vaccine.
In collaboration with the Department of Health and Human Services, Novavax researchers assessed the neutralizing antibody response to its COVID-19 vaccine (NVX-CoV2373) in a phase 3 clinical trial among adolescents from April 26 to June 5, 2021.

View Post

HIV Vaccine Research Accelerates with Government Funding

In COVID-19, Latest News by Precision Vaccinations

While millions of people worldwide await the launch of an HIV vaccine, the U.S. government recently took action by committing to fund early-stage vaccine candidates.
On April 26, 2023, Uvax Bio, LLC announced that its HIV vaccine candidates had shown significantly improved immune response compared with current vaccine strategies.

View Post

Rift River Fever Vaccine Candidate Competes Phase 1 Study

In COVID-19, Latest News by Precision Vaccinations

In this issue of The Lancet Infectious Diseases, Daniel Jenkin and colleagues reported the results of a phase 1 study of a new ChAdOx1 vector vaccine against Rift Valley fever (RVF).
RVF is a viral zoonosis that primarily affects animals but can infect humans.
The development of an effective human vaccine against RVF that elicits a long-term immune response is of enormous clinical importance, wrote these researchers on April 12, 2023.

View Post

New Malaria Vaccine Takes Orders

In COVID-19, Latest News by Precision Vaccinations

Two African nations became the first countries to approve the new R21/Matrix-M™ malaria vaccine, developed at Oxford University, includes Novavax's world-class adjuvant, and is manufactured by the Serum Institute of India (SII), Pvt. Ltd. 
This year, Ghana and Nigeria preempted the World Health Organization (WHO) process and issued their approvals. And about ten other African countries may issue their approvals soon.

View Post

U.S. NIH Herpes Strategic Plan Seeks Proposals

In COVID-19, Latest News by Precision Vaccinations

Over the past decade, the United States has witnessed alarming increases in rates of sexually transmitted infections (STIs), amounting to a public health crisis.
The consequences of the STI epidemic are enormous, wrote the U.S. HHS.
When left untreated, STIs can lead to long-term, irreversible health outcomes such as chronic pelvic pain, infertility, adverse pregnancy outcomes, neonatal death, and congenital abnormalities.

View Post

Where Did This Bird Flu Outbreak Originate

In COVID-19, Latest News by Precision Vaccinations

A team of researchers has tracked the arrival and progression of H5N1 bird flu (Avian influenza) outbreaks in Canada, Mexico, and the United States.
Led by the University of Maryland (UMD) researchers, this team found an unusual change from seasonal highly pathogenic avian influenza (HAPI) to year-round infections and a far more significant impact on birds, mammals, and people.